FDA Clearance Tracker · P000008
LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM
Last checked: Nov 20, 2026Latest source record: Jun 5, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Jun 5, 2001
Approved
Time to decision
482 days
Received Feb 9, 2000. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P000008
- Device name
- LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM
- Applicant
- Medtimo, Inc.
- Applicant location
- Eden Prairie, MN
- Received
- Feb 9, 2000
- Decided
- Jun 5, 2001
- Decision
- Approved
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 46 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE LAP-BAND. ADJUSTABLE GASTRIC BANDING (LAGB.) SYSTEM. THE DEVICE IS INDICATED FOR USE IN WEIGHT REDUCTION FOR SEVERELY OBESE PATIENTS WITH A BODY MASS INDEX (BMI) OF AT LEAST 40 OR A BMI OF AT LEAST 35 WITH ONE OR MORE SEVERE COMORBID CONDITIONS, OR THOSE WHO ARE 100 LBS. OR MORE OVER THEIR ESTIMATED IDEAL WEIGHT ACCORDING TO THE 1983 METROPOLITAN LIFE INSURANCE TABLES (USE THE MIDPOINT FOR MEDIUM FRAME). IT IS INDICATED FOR USE ONLY IN SEVERELY OBESE ADULT PATIENTS WHO HAVE FAILED MORE CONSERVATIVE WEIGHT-REDUCTION ALTERNATIVES, SUCH AS SUPERVISED DIET, EXERCISE AND BEHAVIOR MODIFICATION PROGRAMS. PATIENTS WHO ELECT TO HAVE THIS SURGERY MUST MAKE THE COMMITMENT TO ACCEPT SIGNIFICANT CHANGES IN THEIR EATING HABITS FOR THE REST OF THEIR LIVES.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LTI. The earliest in FDA's data is P840025-S001, decided Dec 18, 1985.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtimo, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P160001 · Decided Sep 8, 2016 · 245 days after receipt
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.